Name: Beyond AI: The Human Advantage in Pharma Competitive Intelligence
Start: 2026-09-17T09:55:00-0400
End: 2026-09-17T10:25:00-0400

Beyond AI: The Human Advantage in Pharma Competitive Intelligence

Thursday September 17, 2026 9:55am - 10:25am EDT

Junior Ballroom C

FENIX conducted qualitative interviews with 42 pharma stakeholders and CI professionals to explore how AI is being adopted, where it creates value and where it continues to fall short. Drawing on these perspectives and selected case studies, this session examines the emerging CI ecosystem and how human and artificial intelligence can work together.

Key takeaways:

Where AI is already transforming CI workflows, and where it falls short
Why human expertise remains essential for interpreting subtle signals and strategic meaning
How AI’s speed and scale combine with human context, judgment, and leadership

Speakers

Pedro Fontana, MBA

Vice President, Growth & Strategy, Fenix Group International

Pedro Fontana is VP of Growth and Strategy at FENIX, a global life sciences strategy and competitive intelligence consultancy. His 10+ years of experience advising leading pharma companies include roles as a Principal in IQVIA’s Asset and Portfolio Strategy practice and as a Senior... Read More →

Erika Dahl, Ph.D.

Senior Project Lead, Fenix Group International

Erika Dahl is a competitive intelligence leader at Fenix Group International, a life sciences consulting and technology company primarily partnering with pharmaceutical, biotechnology, and healthcare organizations. She supports life science organizations with market insights and strategic... Read More →

Thursday September 17, 2026 9:55am - 10:25am EDT
Junior Ballroom C

Track A

Pharma CI USA Conference 2026

Pedro Fontana, MBA

Erika Dahl, Ph.D.

Get help with the event

Pharma CI USA Conference 2026

Pedro Fontana, MBA

Erika Dahl, Ph.D.

Log in to save this to your schedule, view media, leave feedback and see who's attending!

Get help with the event